What to Expect from Your Mounjaro Pen After 3 Doses

Why results at three doses do not reflect where treatment ends up

A misconception our prescribers hear regularly is that Mounjaro has not worked if weight loss is modest or absent after a few injections. The licensed schedule starts at 2.5mg specifically to reduce side effects during the early weeks. That first pen is an adjustment phase. The SURMOUNT-1 trial results that informed NICE's appraisal of tirzepatide were measured at 72 weeks, across a full titration from starter to maintenance doses. Comparing your three-dose experience against a 72-week endpoint is, quite simply, too early.

In practice, appetite suppression tends to become more noticeable after dose increases, not from the outset. Some people feel a real change in hunger within the first couple of weeks; others notice very little at 2.5mg and a marked shift once they move to 5mg, and the full prescribing detail for that step is set out in the Mounjaro SPC for the 5mg dose. Both are within the range of normal responses described in the clinical data. The job of the first pen is to get your body accustomed to tirzepatide, the dual GIP and GLP-1 receptor agonist that makes Mounjaro distinct from other weight-loss medicines. Settling your system down is progress, even when the scales do not yet reflect it.

If you are curious about how experience tends to shift from pen to pen, the picture at two doses is covered in our guide to what to expect from your Mounjaro pen after 2 doses.

Side effects around the three-dose mark: patterns from the evidence

Gastrointestinal effects — nausea, loose stools, constipation, reflux — are the most commonly reported at this stage. They follow a recognisable pattern in trial data: highest incidence close to the start of treatment or after a step-up, then tapering over the following week or two for most people. By the third dose, many people find GI symptoms have already settled from where they were on the first injection, though this is not universal.

Fatigue, mild headache and injection-site reactions are also reported in the early weeks. These do not generally persist through the full titration. If any symptom feels severe, unusual or is not improving, that is a conversation to have with your prescriber, not something to monitor quietly.

One specific symptom requires prompt attention at any dose: severe stomach pain that does not pass and that radiates toward the back, with or without vomiting, should be assessed by a clinician the same day. The MHRA highlighted acute pancreatitis as an infrequent but serious risk in its January 2026 Drug Safety Update for GLP-1 medicines; you can read the broader safety context and report unexpected effects via the Yellow Card scheme. Catching something early is always the right call.

Injection technique can also affect tolerability. Rotating between the abdomen, thigh and upper arm reduces localised soreness. Full storage and injection guidance lives in the Patient Information Leaflet included with your pen.

What happens when the first pen runs out: the clinical review moment

Three doses in means you are approaching the end of your first pen, or you have just used the last injection. At this point, most titration schedules call for a review before moving from 2.5mg to 5mg. That step-up is not automatic. A prescriber looks at how you tolerated the starting dose, whether any symptoms need managing, and whether it is clinically appropriate to proceed.

At a service like nume, every repeat order goes through a fresh clinical review before anything is dispensed. There are no automated renewals. A real clinician checks your progress. If you want to understand what that process involves, the Mounjaro overview page covers how the titration schedule works across the full treatment course, and our clinical team is available seven days a week for aftercare questions.

For anyone wondering about the cost of continuing treatment, a straightforward breakdown is on our Mounjaro price comparison page, which explains what to look for in any provider's pricing.

Practical things worth knowing at this stage of your pen

Your pen stays refrigerated between 2°C and 8°C when not in use. If you need to travel or store it outside the fridge for a period, the Patient Information Leaflet gives the exact window permitted at room temperature. Do not rely on general advice from any content online, including this page, for that detail; the leaflet is the definitive source.

If your pen jammed or failed to deliver the third dose cleanly, that is a separate and common enough question to deserve its own answer. Our guide to a jammed Mounjaro pen after 3 doses walks through what to check and when to contact support.

Looking ahead to what the next pen stage involves? The four-dose mark guide covers what most people notice once the first full cycle is complete. And if you are thinking about what clinical assessment is needed before a dose increase, speaking to our prescribers is the natural next step.

Mounjaro is a prescription-only medicine. Suitability, dosing decisions and any changes to your schedule are always determined by a qualified prescriber, not by a general guide like this one. If you have not yet started and want to understand whether treatment might suit you, our free consultation is the place to begin. Speak to our prescribers and get a same-day clinical review from a GPhC-registered Independent Prescriber.